<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02584868</url>
  </required_header>
  <id_info>
    <org_study_id>2011-006034-17</org_study_id>
    <nct_id>NCT02584868</nct_id>
  </id_info>
  <brief_title>Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid</brief_title>
  <acronym>COLCHIRCARD</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Fabiola Children's University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen Fabiola Children's University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the clinical efficacy and safety of Volulyte® and Voluven® during&#xD;
      elective open-heart surgery in pediatric patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2013</start_date>
  <completion_date type="Actual">November 21, 2016</completion_date>
  <primary_completion_date type="Actual">November 21, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calculated Blood Loss at 3rd Post Operative Day (POD)</measure>
    <time_frame>72H post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Blood Loss</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
    <description>peri-operative blood losses in ml/kg at the end of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest Tube Drainage</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Total chest tube drainage during Pediatric Intensive Care Unit (PICU) stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Blood Loss</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Total blood loss Intraoperative + chest tube drainage during Pediatric Intensive Care Unit (PICU) stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exposure to Any Blood Products</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Transfusion of any blood product (intraoperative + during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exposure to Red Blood Cell</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Transfusion of Red Blood Cell (intraoperative + during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Red Blood Cell Transfused</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Red Blood Cell transfused in transfused patients in ml/kg (intraoperative + during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exposure to Fresh Frozen Plasma</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Transfusion of Fresh Frozen Plasma (intraoperative and during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fresh Frozen Plasma Transfused</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Fresh Frozen Plasma transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exposure to Platelets</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Transfusion of platelets (intraoperative and during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet Transfused</measure>
    <time_frame>72H post surgery</time_frame>
    <description>Platelet transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-Reactive Protein (CRP)</measure>
    <time_frame>At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTT</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APTT</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>INR</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrinogen</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clotting Time in Seconds</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
    <description>Clotting time on EXTEM ROTEM®</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Cloth Firmness</measure>
    <time_frame>End of surgery, an average of 200 minutes</time_frame>
    <description>Maximal cloth firmness on EXTEM ROTEM®</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>Post-operative Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>Post-operative Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTT</measure>
    <time_frame>Post-operative Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APTT</measure>
    <time_frame>Post-operative Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>INR</measure>
    <time_frame>Post-operative Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrinogen</measure>
    <time_frame>Post-operative Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>Post-operative Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>Post-operative Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTT</measure>
    <time_frame>Post-operative Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APTT</measure>
    <time_frame>Post-operative Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>INR</measure>
    <time_frame>Post-operative Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrinogen</measure>
    <time_frame>Post-operative Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>Post-operative Day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>Post-operative Day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>Volulyte</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational drug: HES 130/0.4 (6%) in an isotonic electrolyte solution (brand name=Volulyte®)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Voluven</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control drug: HES 130/0.4 (6%) in sodium chloride 0.9% (brand name=Voluven®)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution</intervention_name>
    <description>Peri-operative fluid replacement therapy (max 40ml/kg/day)</description>
    <arm_group_label>Volulyte</arm_group_label>
    <other_name>Volulyte</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyethyl starch 130/0.4 in 0.9% sodium chloride</intervention_name>
    <description>Peri-operative fluid replacement therapy (max 40ml/kg/day)</description>
    <arm_group_label>Voluven</arm_group_label>
    <other_name>Voluven</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 28 days to 3 years old&#xD;
&#xD;
          -  Planned cardiac surgery with cardiopulmonary by-pass&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Moribund patients (ASA 5)&#xD;
&#xD;
          -  Jehovah Witnesses&#xD;
&#xD;
          -  Pre-operative coagulation disorders&#xD;
&#xD;
          -  Pre-operative renal insufficiency&#xD;
&#xD;
          -  Pre-operative hepatic disorders&#xD;
&#xD;
          -  Intra-cranial hemorrhage&#xD;
&#xD;
          -  hypernatremia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Van der Linden, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HUDERF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Universitaire Des Enfants Reine Fabiola</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>July 3, 2013</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2015</study_first_posted>
  <results_first_submitted>June 10, 2020</results_first_submitted>
  <results_first_submitted_qc>October 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 9, 2020</results_first_posted>
  <last_update_submitted>October 16, 2020</last_update_submitted>
  <last_update_submitted_qc>October 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Saline Colloid</title>
          <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
        </group>
        <group group_id="P2">
          <title>Balanced Colloid</title>
          <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Children undergoing cardiac surgery with cardiopulmonary bypass - perioperative period</population>
      <group_list>
        <group group_id="B1">
          <title>Saline Colloid</title>
          <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
        </group>
        <group group_id="B2">
          <title>Balanced Colloid</title>
          <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="88"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="44"/>
                    <count group_id="B2" value="44"/>
                    <count group_id="B3" value="88"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="44"/>
                    <count group_id="B2" value="44"/>
                    <count group_id="B3" value="88"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.3" lower_limit="4.5" upper_limit="13.7"/>
                    <measurement group_id="B2" value="6.9" lower_limit="5.2" upper_limit="16.1"/>
                    <measurement group_id="B3" value="6.6" lower_limit="5.0" upper_limit="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="44"/>
                    <count group_id="B2" value="44"/>
                    <count group_id="B3" value="88"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Belgium</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="44"/>
                    <count group_id="B2" value="44"/>
                    <count group_id="B3" value="88"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Calculated Blood Loss at 3rd Post Operative Day (POD)</title>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Calculated Blood Loss at 3rd Post Operative Day (POD)</title>
          <units>ml/kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.9" lower_limit="13.8" upper_limit="26.1"/>
                    <measurement group_id="O2" value="15.9" lower_limit="9.0" upper_limit="25.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraoperative Blood Loss</title>
        <description>peri-operative blood losses in ml/kg at the end of surgery</description>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Blood Loss</title>
          <description>peri-operative blood losses in ml/kg at the end of surgery</description>
          <units>ml/kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" lower_limit="2.8" upper_limit="7.2"/>
                    <measurement group_id="O2" value="4.8" lower_limit="2.9" upper_limit="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chest Tube Drainage</title>
        <description>Total chest tube drainage during Pediatric Intensive Care Unit (PICU) stay</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Chest Tube Drainage</title>
          <description>Total chest tube drainage during Pediatric Intensive Care Unit (PICU) stay</description>
          <units>ml/kg</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8" lower_limit="11.8" upper_limit="27.7"/>
                    <measurement group_id="O2" value="18.8" lower_limit="14.8" upper_limit="28.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Blood Loss</title>
        <description>Total blood loss Intraoperative + chest tube drainage during Pediatric Intensive Care Unit (PICU) stay</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Total Blood Loss</title>
          <description>Total blood loss Intraoperative + chest tube drainage during Pediatric Intensive Care Unit (PICU) stay</description>
          <units>ml/kg</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.7" lower_limit="18.7" upper_limit="34.0"/>
                    <measurement group_id="O2" value="23.4" lower_limit="18.4" upper_limit="34.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exposure to Any Blood Products</title>
        <description>Transfusion of any blood product (intraoperative + during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Exposure to Any Blood Products</title>
          <description>Transfusion of any blood product (intraoperative + during Pediatric Intensive Care Unit stay)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exposure to Red Blood Cell</title>
        <description>Transfusion of Red Blood Cell (intraoperative + during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Exposure to Red Blood Cell</title>
          <description>Transfusion of Red Blood Cell (intraoperative + during Pediatric Intensive Care Unit stay)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Red Blood Cell Transfused</title>
        <description>Red Blood Cell transfused in transfused patients in ml/kg (intraoperative + during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Red Blood Cell Transfused</title>
          <description>Red Blood Cell transfused in transfused patients in ml/kg (intraoperative + during Pediatric Intensive Care Unit stay)</description>
          <units>ml/kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.9" lower_limit="18.4" upper_limit="38.5"/>
                    <measurement group_id="O2" value="26.1" lower_limit="15.7" upper_limit="44.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exposure to Fresh Frozen Plasma</title>
        <description>Transfusion of Fresh Frozen Plasma (intraoperative and during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Exposure to Fresh Frozen Plasma</title>
          <description>Transfusion of Fresh Frozen Plasma (intraoperative and during Pediatric Intensive Care Unit stay)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fresh Frozen Plasma Transfused</title>
        <description>Fresh Frozen Plasma transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Fresh Frozen Plasma Transfused</title>
          <description>Fresh Frozen Plasma transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay)</description>
          <units>ml/kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.6" lower_limit="9.3" upper_limit="46.4"/>
                    <measurement group_id="O2" value="12.2" lower_limit="10.1" upper_limit="26.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exposure to Platelets</title>
        <description>Transfusion of platelets (intraoperative and during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Exposure to Platelets</title>
          <description>Transfusion of platelets (intraoperative and during Pediatric Intensive Care Unit stay)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Platelet Transfused</title>
        <description>Platelet transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay)</description>
        <time_frame>72H post surgery</time_frame>
        <population>No platelet transfusion performed in subjects enrolled in the balanced colloid group</population>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Platelet Transfused</title>
          <description>Platelet transfusion in ml/kg (intraoperative and during Pediatric Intensive Care Unit stay)</description>
          <population>No platelet transfusion performed in subjects enrolled in the balanced colloid group</population>
          <units>ml/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine</title>
        <time_frame>At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" lower_limit="0.24" upper_limit="0.33"/>
                    <measurement group_id="O2" value="0.29" lower_limit="0.25" upper_limit="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>C-Reactive Protein (CRP)</title>
        <time_frame>At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>C-Reactive Protein (CRP)</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="1.4" upper_limit="5.0"/>
                    <measurement group_id="O2" value="5.0" lower_limit="1.8" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTT</title>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>PTT</title>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.1" spread="9.4"/>
                    <measurement group_id="O2" value="50.1" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>APTT</title>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>APTT</title>
          <units>seconde</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.4" spread="5.8"/>
                    <measurement group_id="O2" value="38.6" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>INR</title>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>INR</title>
          <units>ratio</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" lower_limit="1.4" upper_limit="1.7"/>
                    <measurement group_id="O2" value="1.5" lower_limit="1.4" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fibrinogen</title>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Fibrinogen</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="159.0" spread="51.0"/>
                    <measurement group_id="O2" value="148.0" spread="38.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clotting Time in Seconds</title>
        <description>Clotting time on EXTEM ROTEM®</description>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Clotting Time in Seconds</title>
          <description>Clotting time on EXTEM ROTEM®</description>
          <units>secondes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.5" lower_limit="72.8" upper_limit="111.3"/>
                    <measurement group_id="O2" value="88.0" lower_limit="59.0" upper_limit="103.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximal Cloth Firmness</title>
        <description>Maximal cloth firmness on EXTEM ROTEM®</description>
        <time_frame>End of surgery, an average of 200 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Cloth Firmness</title>
          <description>Maximal cloth firmness on EXTEM ROTEM®</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="42.8" upper_limit="55.0"/>
                    <measurement group_id="O2" value="48.0" lower_limit="42.0" upper_limit="52.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine</title>
        <time_frame>Post-operative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" lower_limit="0.24" upper_limit="0.46"/>
                    <measurement group_id="O2" value="0.30" lower_limit="0.26" upper_limit="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CRP</title>
        <time_frame>Post-operative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>CRP</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.3" lower_limit="23.5" upper_limit="45.0"/>
                    <measurement group_id="O2" value="39.5" lower_limit="25.8" upper_limit="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTT</title>
        <time_frame>Post-operative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>PTT</title>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.5" lower_limit="75.0" upper_limit="96.8"/>
                    <measurement group_id="O2" value="81.0" lower_limit="71.0" upper_limit="99.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>APTT</title>
        <time_frame>Post-operative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>APTT</title>
          <units>seconde</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.2" lower_limit="28.9" upper_limit="35.7"/>
                    <measurement group_id="O2" value="34.7" lower_limit="31.1" upper_limit="38.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>INR</title>
        <time_frame>Post-operative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>INR</title>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" lower_limit="1.0" upper_limit="1.2"/>
                    <measurement group_id="O2" value="1.1" lower_limit="1.0" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fibrinogen</title>
        <time_frame>Post-operative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Fibrinogen</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="345.0" spread="83.0"/>
                    <measurement group_id="O2" value="365.0" spread="94.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine</title>
        <time_frame>Post-operative Day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" lower_limit="0.22" upper_limit="0.34"/>
                    <measurement group_id="O2" value="0.27" lower_limit="0.22" upper_limit="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CRP</title>
        <time_frame>Post-operative Day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>CRP</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.0" lower_limit="23.2" upper_limit="55.6"/>
                    <measurement group_id="O2" value="43.5" lower_limit="27.4" upper_limit="65.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTT</title>
        <time_frame>Post-operative Day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>PTT</title>
          <units>percent</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.0" lower_limit="72.0" upper_limit="96.0"/>
                    <measurement group_id="O2" value="80.5" lower_limit="71.8" upper_limit="97.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>APTT</title>
        <time_frame>Post-operative Day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>APTT</title>
          <units>seconde</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.5" lower_limit="28.7" upper_limit="35.7"/>
                    <measurement group_id="O2" value="33.2" lower_limit="29.2" upper_limit="36.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>INR</title>
        <time_frame>Post-operative Day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>INR</title>
          <units>ratio</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" lower_limit="1.0" upper_limit="1.2"/>
                    <measurement group_id="O2" value="1.1" lower_limit="1.0" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fibrinogen</title>
        <time_frame>Post-operative Day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Fibrinogen</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="346.2" spread="82.2"/>
                    <measurement group_id="O2" value="352.6" spread="90.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine</title>
        <time_frame>Post-operative Day 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" lower_limit="0.18" upper_limit="0.32"/>
                    <measurement group_id="O2" value="0.24" lower_limit="0.19" upper_limit="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CRP</title>
        <time_frame>Post-operative Day 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Saline Colloid</title>
            <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
          </group>
          <group group_id="O2">
            <title>Balanced Colloid</title>
            <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
          </group>
        </group_list>
        <measure>
          <title>CRP</title>
          <units>mg/dl</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.0" lower_limit="22.0" upper_limit="53.7"/>
                    <measurement group_id="O2" value="29.6" lower_limit="19.8" upper_limit="49.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>through study completion, an average of 14 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Saline Colloid</title>
          <description>6% Hydroxyethyl starch 130/0.4 in NaCl 0.9% (Voluven®)</description>
        </group>
        <group group_id="E2">
          <title>Balanced Colloid</title>
          <description>6% hydroxyethyl starch 130/0.4 in an isotonic solution of electrolytes (Volulyte®)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyponatremia (Na&lt;130)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Hypernatremia (Na&gt;150)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Hyperchloremia (Cl&gt;115)</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Philippe Van der Linden, MD, PhD</name_or_title>
      <organization>Centre Hospitalier Universitaire Brugmann</organization>
      <phone>+32 2 477 23 30</phone>
      <email>philippe.vanderlinden@chu-brugmann.be</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

